CClinicalTrials.gg
RecruitingNCT04671381Updated Oct 30, 2024

Improving Access and Affordability of Adult Hearing Healthcare

An interventional study of Hearing Evaluation and Over-the-Counter Hearing Aid (OTC HA) Fitting and Orientation in Hearing Loss, sponsored by University of Alabama, Tuscaloosa. Recruiting at 1 site in United States. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-30.

Sponsored by University of Alabama, Tuscaloosa · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

This project will address quality of care issues associated with hearing loss in adults who have mild-to-moderate hearing loss and who have no access to hearing healthcare. Through the use of three different interventions involving over-the-counter hearing aids, it will lead to options that will increase access and affordability of hearing healthcare for adults with mild-to-moderate hearing loss.

Read the detailed description

The design for this study is outlined below according to each Aim.

Aim 1: To identify the effectiveness of over-the-counter hearing aids (OTC HAs) for decreasing hearing handicap and improving speech perception in adults with no access to hearing health care.

Aim 2: To implement an adult aural rehabilitation (AR) program for those without access to hearing health care to improve OTC HA benefit, promote OTC HA use and lead to increased quality of life (QOL).

Aim 1 will assess the effectiveness of OTC HAs for our participant population and Aim 2 will implement an AR program. With Aim 1, hearing loss will be assessed and an OTC HA will be provided. Prior to the hearing evaluation, participants will be randomly placed in one of three groups to assess the effectiveness of the AR program (Aim 2). The three groups include those who will receive the current best practices care from an audiologist (ABP), those who will receive the ABP plus an aural rehabilitation program (ABP+AR), and finally, those who will receive only an OTC HA without assistance from an audiologist for providing programming, maintenance or care information (OTC-only). Both the ABP and OTC-only groups initially will attend general health information sessions in-place of the AR program. Local health care providers who have training in general health areas such as nutrition, diabetes, obesity, and heart health to name a few, will provide the General Health and Wellness programming. Once the ABP+AR groups have completed their AR sessions, the ABP and the OTC-only groups will attend the AR programming sessions. This testing layout and schedule is provided in the table below.

Randomization will occur for each county visited and for the participants. Specifically, five counties will each receive a code and these codes will be randomized to determine when the study will take place in that area. All five regions will be included over a one-year period. Participant randomization will occur by generating three groups of random participant numbers and then assigning each participant to their designated group. Only the PI and the project manager will have access to the randomization lists. The PI will generate the randomization lists and the Project Manager will assign the participants accordingly to each group. The randomization lists will be kept on a password-protected computer and only accessible by the PI or Project Manager.

Audiologists will be blinded to the intervention condition for participants. Specifically, two audiologists (A1 and A2) will conduct the initial hearing evaluations. A2 will perform the OTC HA settings and orientations and a third audiologist (A3) will perform the follow-up speech perception testing in weeks 8 - 9. A second post-speech perception testing for all participants in week 14 will be conducted by A1.

The entire program will take place over a 14-week period for one county at a time. County 1 will begin at Week 1 and the remaining four regions will be stratified such that testing will begin at Week 9, 10 or 11 consecutively for each region. The stratification will be done to ensure that testing takes place in each area over a one-year period, and also, to avoid simultaneous testing at two sites. Finally, all participants who complete the study in years 1 and 2 will be invited back to complete speech perception testing and the AR surveys one year after they complete the study.

02

Conditions studied

  • Hearing Loss

Browse trials for

03

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Mild-to-moderate hearing loss
  • Live in West Central or South Alabama
  • 40 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Medical conditions resulting in severe cognitive impairment (e.g., stroke, head injury, senile dementia or Alzheimer's disease)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    Audiology Best Practices plus Aural Rehabilitation (ABP+AR)

    This experimental group will receive a hearing evaluation, an over-the-counter hearing aid fitting and orientation, and four-weeks of an aural rehabilitation program conducted by specially-trained community health workers. Additionally, these adults will complete pre- and post-questionnaires and speech perception testing.

    Behavioral: Hearing Evaluation · Device: Over-the-Counter Hearing Aid (OTC HA) Fitting and Orientation · Behavioral: Four Weeks of Aural Rehabilitation

  • Active comparator
    Audiology Best Practices (ABP)

    This comparison group of adults with hearing loss will receive a hearing evaluation and over-the-counter hearing aid fitting and orientation. The aural rehabilitation program will not be provided initially. These participants will complete pre- and post-questionnaires and speech perception testing.

    Behavioral: Hearing Evaluation · Behavioral: Four Weeks of Aural Rehabilitation

  • Active comparator
    Over-the-Counter Only (OTC-Only)

    This comparison group of adults with hearing loss will receive a hearing evaluation. They will be provided with over-the-counter hearing aids but the audiologist will not assist with fitting the aids or providing an orientation. This arm mimics what would happen when a consumer privately purchases over-the-counter hearing aids. They will complete pre- and post-questionnaires and speech perception testing.

    Behavioral: Hearing Evaluation · Device: Provision of Over-the-Counter Hearing Aids

Interventions

  • BehavioralHearing Evaluation

    Behavioral thresholds for pure tones will be conducted along with speech perception measures.

  • DeviceOver-the-Counter Hearing Aid (OTC HA) Fitting and Orientation

    Study participants will be fitted with binaural OTC HAs in addition to receiving information on how to use and care for their devices.

    Also known as: Over-the-Counter Hearing Aid Fitting and Orientation

  • BehavioralFour Weeks of Aural Rehabilitation

    Participants will receive four weeks of information sessions to help them adjust to their over-the-counter hearing aid and their hearing loss.

  • DeviceProvision of Over-the-Counter Hearing Aids

    Study participants will receive binaural OTC HAs. Participants will fit their OTC HAs based on manufacturer guidelines without the help of an audiologist.

    Also known as: Provision of Over-the Counter Hearing Aids

05

What researchers measure

Primary outcomes

  1. Measuring Change in the Hearing Handicap Inventory for Elderly (HHIE) Outcomes

    Twenty-five questions of the Hearing Handicap Inventory for Elderly (HHIE) measure emotional and social/situational consequences of hearing loss, including feelings of embarrassment, social isolation, and frustration. Scores range from 0 to 100 with higher scores indicative of poorer performance.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

  2. Measuring Change in International Outcome Inventory for Hearing Aids (IOI-HA) Outcomes

    The International Outcome Inventory for Hearing Aids (IOI-HA) is an eight-item inventory that assesses daily use of over-the-counter hearing aid use, over-the-counter hearing aid benefit, and activity limitations to name a few. This is a scaled qualitative measure that assesses outcomes over time.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

Secondary outcomes

  1. Measuring Change in Northwestern University-6 (NU-6) Word Recognition Outcomes

    This test will assess word recognition in quiet. Binaural testing will be performed at 65 dBA in the sound field. A percentage correct word understanding will be obtained. A higher scores is indicative of better performance.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 8 to 9 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

  2. Measuring Change in Quick Speech In Noise (SIN) Word Recognition Outcomes

    The participant will be instructed to repeat the presented sentences in noise via a speaker presented at 0˚ azimuth. The correctly identified target words will be totaled and then subtracted from 25.5 to obtain the Signal-to-Noise Ratio (SNR) loss. A higher score is indicative of poorer performance.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 8 to 9 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

  3. Measuring Change in the Client Oriented Scale of Improvement (COSI)

    The Client Oriented Scale of Improvement (COSI) is a 16-item clinician-administered survey that addresses how the participants' five most important listening difficulties have been alleviated with over-the-counter hearing aid use. This is a qualitative scale that measures improvement over time.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

  4. Measuring Change in the Abbreviated Profile of Hearing Aid Benefit (APHAB)

    The Abbreviated Profile of Hearing Aid Benefit (APHAB) is a 24-item survey that computes OTC HA-benefit by calculating the difference between aided and unaided conditions. It is a qualitative scale that measures the extent of change over time.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

  5. Measuring Change in the World Health Organization Quality of Life-Age (WHOQOL-AGE) Survey

    The World Health Organization Quality of Life-Age (WHOQOL-AGE) survey is a 13-item scale that examines quality of life in adults as they age. It is a qualitative rating scale that can help to identify change in performance over time.

    Time frame: A baseline outcome will be obtained prior to over-the-counter hearing aid fitting. Outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.

06

Study locations

1 of 1 sites recruiting
  • The University of Alabama
    Tuscaloosa, Alabama 35487, United States
    Recruiting
07

References and documents

Publications

  • Tillman TW, Carhart R. An expanded test for speech discrimination utilizing CNC monosyllabic words. Northwestern University Auditory Test No. 6. SAM-TR-66-55. Tech Rep SAM-TR. 1966 Jun:1-12. doi: 10.21236/ad0639638. No abstract available. PubMed 5296571 ↗
  • Schow RL, Nerbonne MA. Communication screening profile: use with elderly clients. Ear Hear. 1982 May-Jun;3(3):135-47. doi: 10.1097/00003446-198205000-00007. No abstract available. PubMed 7095322 ↗
  • Cox RM, Alexander GC. The International Outcome Inventory for Hearing Aids (IOI-HA): psychometric properties of the English version. Int J Audiol. 2002 Jan;41(1):30-5. doi: 10.3109/14992020209101309. PubMed 12467367 ↗
  • Dillon H, James A, Ginis J. Client Oriented Scale of Improvement (COSI) and its relationship to several other measures of benefit and satisfaction provided by hearing aids. J Am Acad Audiol. 1997 Feb;8(1):27-43. PubMed 9046067 ↗
  • Cox RM, Alexander GC. The abbreviated profile of hearing aid benefit. Ear Hear. 1995 Apr;16(2):176-86. doi: 10.1097/00003446-199504000-00005. PubMed 7789669 ↗
  • Caballero FF, Miret M, Power M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Olaya B, Haro JM, Ayuso-Mateos JL. Validation of an instrument to evaluate quality of life in the aging population: WHOQOL-AGE. Health Qual Life Outcomes. 2013 Oct 23;11:177. doi: 10.1186/1477-7525-11-177. PubMed 24152691 ↗
  • Etymotic. QuickSIN Speech-in-Noise Test. Elk Grove Village, IL 2006.

Study documents

  • Informed consent form · Jul 26, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — All of the individual participant data that has been collected during this clinical trial and after it has been de-identified will be shared.

Supporting information: Study protocol

08

Registry details

Key details

Study ID
NCT04671381
Lead sponsor
University of Alabama, Tuscaloosa
Collaborators
University of Alabama at Birmingham
Responsible party
Sponsor
First posted
Dec 17, 2020
Start date
Jan 1, 2021
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Oct 30, 2024

Study contacts

Marcia J Hay-McCutcheon, PhD
Contact
mhaymccu@ua.edu
205-348-4572
Marcia J Hay-McCutcheon, PhD
principal investigator · The University of Alabama, Tuscaloosa

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion